BioNTech: Navigating Challenges and Innovations Beyond the Pandemic
BioNTech is transitioning from pandemic profits to focusing on mRNA-based cancer therapies, highlighting a major strategic shift. The company recorded a decrease in earnings for 2024, with fourth-quarter earnings per…